DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Marconi VC, Ramanan AV, de Bono S. et al.
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial.
Lancet Respir Med 2021;
DOI: 10.1016/S2213-2600(21)00331-3.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.